The latest issues of Housecalls: Underwriting Case Studies & Insights includes a case involving anaphylaxis.
Disruptive Innovation— Coming to Insurance near You
Disruptive innovation are revolutionizing many industries. How will it affect insurance?
Click on "Issue 88, July." Article states on page 20.
Accelerated Underwriting - Be Sure Your Company Gets It Right
Have you seen the SOA's recently released "Predictive Analytics & Accelerated Underwriting Survey Report"? It is a terrific reminder of what an interesting time it is to be an underwriter, actuary or data scientist in the U.S. life and health insurance industry.
Recreational Marijuana – Where’s the Risk?
In 2015 we published a white paper with an underwriting perspective on marijuana use. The following paper takes a look at the developing landscape after two years.
Master the Facultative Submission Puzzle
Life insurance underwriting isn’t just a job – it’s an art, a science and, at times, a puzzle. To piece together a particularly complex or challenging case, it often makes sense to seek facultative consideration from a reinsurer. Find tips and tools here to make the process easier, including a sample cover letter.
Opioid Epidemic – How Did We Get Here?
This paper seeks to understand the unique set of circumstances that led to the dramatic rise in opioid prescriptions over the last few decades, and provide a brief overview of the resultant morbidity and mortality for the insured population.
The Challenges of Determining Worth - Financial Underwriting In Emerging Markets
How much is a life worth? That is a difficult question to answer. Addressing it from a social, emotional, or spiritual perspective can provide a wide range of responses – if in fact the question is answerable at all. From a strictly fiscal perspective, however, determining a person’s long-term financial value is exactly what financial underwriting in life insurance seeks to do.
Can Big Data Spell the End of Uncertainty?
Big data applications are increasingly shaping our everyday lives, making trends more transparent and patterns more predictable. Like insurance, science, notably medicine, is equally subject to the novel possibilities and demands resulting from big data. Will risks gradually decline as trends and patterns become more predictable in healthcare and for behavior? Are the days of insurance and science as we know them numbered?
Key Issues in Simplified Issue Products (Slides)
Slides from the presentation by Robert Stout, Laboratory Director at Clinical Reference Laboratory delivered at the 2017 Spring Meeting of the Actuaries’ Club of the Southwest.